Editorial
|
| Reaching UnDrugable Intracellular Targets with the Long Arm of Antibodies |
|
https://doi.org/10.18632/oncotarget.1039
|
| 647-648 |
|
| Perturbation of nucleotide metabolism the driving force of oncogeneinduced senescence |
|
https://doi.org/10.18632/oncotarget.1023
|
| 649-650 |
Reviews
|
| To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells |
|
https://doi.org/10.18632/oncotarget.1040
|
| 651-664 |
Research Papers
|
| MicroRNA137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP1 |
|
https://doi.org/10.18632/oncotarget.928
|
| 665-676 |
|
| Cell death sensitization of leukemia cells by opioid receptor activation |
|
https://doi.org/10.18632/oncotarget.952
|
| 677-690 |
|
| Constitutivelyactive androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors |
|
https://doi.org/10.18632/oncotarget.975
|
| 691-704 |
|
| P53 Mutations in Advanced Cancers: Clinical Characteristics Outcomes and Correlation between ProgressionFree Survival and BevacizumabContaining Therapy |
|
https://doi.org/10.18632/oncotarget.974
|
| 705-714 |
|
| Genomewide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations |
|
https://doi.org/10.18632/oncotarget.990
|
| 715-728 |
|
| FAM83Bmediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies |
|
https://doi.org/10.18632/oncotarget.1027
|
| 729-738 |
|
| Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer |
|
https://doi.org/10.18632/oncotarget.1034
|
| 739-750 |
|
| Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LHRH analog AEZS108 |
|
https://doi.org/10.18632/oncotarget.1044
|
| 751-760 |
|
| Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma |
|
https://doi.org/10.18632/oncotarget.1047
|
| 761-771 |
|
| Revisiting Clinical Trials Using EGFR InhibitorBased Regimens in Patients with Advanced NonSmall Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population |
|
https://doi.org/10.18632/oncotarget.1028
|
| 772-784 |
|
| CD44variant exon 9 plays an important role in colon cancer initiating cells |
|
https://doi.org/10.18632/oncotarget.1048
|
| 785-791 |
|
| Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts |
|
https://doi.org/10.18632/oncotarget.1059
|
| 792-801 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
